June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
City of Hope to offer CAR T cell therapy for patients with the most common type of NHL
May 4, 2018 | Letisia Marquez
City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.
Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work
January 12, 2018 | Letisia Marquez
Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.
Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma
December 11, 2017 | Katie Neith
Researchers led by Alex Herrera, M.D. have found that a combination of two immunotherapy drugs may be a more tolerable way for patients to fight the disease before a transplant.
2018 Rose Parade: First pitch symbolizes new beginning for Division 1 baseball player
November 28, 2017 | Denise Heady
For the 46th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, 10 patients will welcome 2018 atop City of Hope’s Rose Parade float. Here, we meet float rider Chad Bible, a 21-year-old college student and Division 1 baseball player at San Diego State University.
2018 Rose Parade: ‘I Just Want to Help’: A Platelet Donor Gives Back to Honor His Mom
October 20, 2017 | Denise Heady
Ever since Bliley's mother passed away from Hodgkin lymphoma when he was 8 years old, he knew he wanted to help other patients like his mom. He just wasn’t sure how. When he turned 18, he finally found a way – by donating platelets to cancer patients who desperately needed transfusions to live.
City of Hope to Provide First FDA-approved CAR T Cell Therapy for Some Types of Lymphoma
October 18, 2017 | City of Hope
City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR T therapy for adult patients who have not responded to or who have relapsed after at least two other kinds of treatment.